Key result
Prophylactic amiodarone for postoperative atrial fibrillation increased the odds of bradycardia (OR 1.70; 95% CI 1.05-2.74) and hypotension (OR 1.62; 95% CI 1.04-2.54).
Why the study?
Does prophylactic amiodarone increase the risk of adverse safety endpoints in patients undergoing coronary artery bypass graft or valvular surgery?
Meta-Analysis (n=3,408)
Does prophylactic amiodarone increase the risk of adverse safety endpoints in patients undergoing coronary artery bypass graft or valvular surgery?
Odds Ratio: 1.7 (95% CI 1.05–2.74)
Prophylactic amiodarone for postoperative atrial fibrillation is associated with an increased risk of bradycardia and hypotension, particularly with IV use or doses exceeding 1 g/day.
No takes yet. Share an insight, caveat, or question.
Warrants caution with prophylactic amiodarone after cardiac surgery; confirms adverse safety signals and supports dose-optimization trials.
Patel et al. (2006) conducted a meta-analysis in postoperative atrial fibrillation (n=3,408). Amiodarone vs. Placebo or routine treatment was evaluated on Bradycardia (OR 1.70, 95% CI 1.05-2.74). Prophylactic amiodarone for postoperative atrial fibrillation increased the odds of bradycardia (OR 1.70; 95% CI 1.05-2.74) and hypotension (OR 1.62; 95% CI 1.04-2.54).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: